ScholarIQanswers from OpenAlex
Teclistamab in Relapsed or Refractory Multiple Myeloma
PaperCitations, authors & open-access status
Teclistamab in Relapsed or Refractory Multiple Myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Teclistamab in Relapsed or Refractory Multiple Myeloma have?
ScholarIQcitation count
Teclistamab in Relapsed or Refractory Multiple Myeloma has 1,160 citations in the OpenAlex counts ScholarIQ stores.
When was Teclistamab in Relapsed or Refractory Multiple Myeloma published?
ScholarIQyear
Teclistamab in Relapsed or Refractory Multiple Myeloma has 2022 year in the ScholarIQ index.
What is the open-access status of Teclistamab in Relapsed or Refractory Multiple Myeloma?
ScholarIQoa status
Teclistamab in Relapsed or Refractory Multiple Myeloma has bronze oa status in the ScholarIQ index.
What is the DOI of Teclistamab in Relapsed or Refractory Multiple Myeloma?
ScholarIQdoi
The DOI for Teclistamab in Relapsed or Refractory Multiple Myeloma is on the source record.
What is the PMID of Teclistamab in Relapsed or Refractory Multiple Myeloma?
ScholarIQpmid
The PMID for Teclistamab in Relapsed or Refractory Multiple Myeloma is on the source record.
What is the OpenAlex record for Teclistamab in Relapsed or Refractory Multiple Myeloma?
ScholarIQopenalex
The OpenAlex for Teclistamab in Relapsed or Refractory Multiple Myeloma is on the source record.